Targacept (TRGT) Income Statement

Click line-items for a historical chart and %

Milestones and license fees from collaborations
Grant revenue
Net operating revenues
Research and development (including stock-based compensation of $1,257 and $748 for the three months ended June 30, 2011 and 2010, respectively and $2,494 and $1,515 for the six months ended June 30, 2011 and 2010, respectively)	3.4M
General and administrative (including stock-based compensation of $943 and $493 for the three months ended June 30, 2011 and 2010, respectively and $1,869 and $963 for the six months ended June 30, 2011 and 2010, respectively)	2.43M
Total operating expenses	5.82M
(Loss) income from operations	-5.71M
Interest income
Interest expense	0
Total other income (expense)
(Loss) income before income taxes
Income tax expense
Net (loss) income	-4.77M
Basic net (loss) income per share
Diluted net (loss) income per share
Weighted average common shares outstanding - basic
Weighted average common shares outstanding - diluted

Entities mentioned with TRGT

View All Entities